Week of February 18 - 24, 2018
Apalutamide (Erleada ™) is an androgen receptor inhibitor indicated for the treatment of non-metastatic castration resistant prostate cancer.
Some people develop ongoing diarrhea, incontinence, and urgency when the bowel is in the radiation treatment area.
Survivors often wonder what steps they can take to live healthier after cancer - we've got answers!
Tisagenlecleucel (Kymriah ™) is a CD19-directed genetically-modified autologous (self-directed) T cell immunotherapy cancer treatment used in the treatment of acute lymphoblastic leukemia.
Axicabtagene Ciloleucel (Yescarta ™) is a CD19-directed genetically-modified autologous (self-directed) T cell immunotherapy cancer treatment used in the treatment of some types of non-Hodgkin lymphoma.
Free continuing education for nurses.
Important information for patients receiving radiation therapy regarding supplement use.
Trastuzumab-dkst (Ogivri) is a biosimilar monoclonal antibody used in the treatment of some types of breast and gastric cancers.
Morgan shares her experience of surviving Melanoma.
In formation about biosimilars - a biologic medication that is almost an exact copy of another medication.
Osteoradionecrosis (ORN) is a possible side effect of radiation treatment for head and neck cancers.
Provides a brief overview of COBRA and how it can assist with maintaining health insurance coverage after a change in employment status.
This treatment used for NETs combines a medication with a radiation source.